Skip to main content

Table 1 Clinical characteristics of patients incorporated into analysis.

From: Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients

Cases

Matched control pairs

Patient number

Age

Fractionation schedule

a Year of follow-up

Patient number

Age

Fractionation schedule

a Year of follow-up

  

Dose/fraction number

Year 1

Year 2

Year 3

Year 4

Year 5

  

Dose/fraction number

Year 1

Year 2

Year 3

Year 4

Year 5

108

61

50 Gy/25

1

1

3

3

3

112

52

50 Gy/25

1

1

1

9

9

90

62

42.9 Gy/13

2

2

2

2

2

75

62

42.9 Gy/13

9

1

1

1

1

132

57

50 Gy/25

2

2

2

2

2

158

54

50 Gy/25

1

1

1

1

1

135

56

42.9 Gy/13

2

2

2

2

2

144

57

39 Gy/13

1

1

1

1

1

137

50

42.9 Gy/13

1

2

2

2

2

148

55

42.9 Gy/13

1

1

1

1

1

138

63

42.9 Gy/13

2

2

2

3

3

126

63

42.9 Gy/13

1

1

1

1

1

115

54

42.9 Gy/13

3

3

2

2

2

123

59

42.9 Gy/13

1

1

9

9

1

98

62

50 Gy/25

3

3

3

3

3

106

44

50 Gy/25

1

1

1

1

1

  1. aPhotographic scores of breast appearance, 1, no change, 2, moderate change, 3, marked change, 9, data unavailable. 10 year data was available for control patients 75, 126 and 106 - these scores were persistently 1. Matched cases and control pairs are presented in each line of the table.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us